GR3033195T3 - Prostaglandin derivatives - Google Patents

Prostaglandin derivatives

Info

Publication number
GR3033195T3
GR3033195T3 GR20000400889T GR20000400889T GR3033195T3 GR 3033195 T3 GR3033195 T3 GR 3033195T3 GR 20000400889 T GR20000400889 T GR 20000400889T GR 20000400889 T GR20000400889 T GR 20000400889T GR 3033195 T3 GR3033195 T3 GR 3033195T3
Authority
GR
Greece
Prior art keywords
formula
blood flow
prostaglandin derivatives
prostaglandin
decubitus
Prior art date
Application number
GR20000400889T
Other languages
English (en)
Inventor
Akio Nishiura
Takuya Seko
Ryoji Matsumoto
Shin-Ichi Hamano
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of GR3033195T3 publication Critical patent/GR3033195T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR20000400889T 1995-08-25 2000-04-12 Prostaglandin derivatives GR3033195T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23898495 1995-08-25

Publications (1)

Publication Number Publication Date
GR3033195T3 true GR3033195T3 (en) 2000-08-31

Family

ID=17038205

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000400889T GR3033195T3 (en) 1995-08-25 2000-04-12 Prostaglandin derivatives

Country Status (9)

Country Link
US (1) US5698590A (el)
EP (1) EP0760366B1 (el)
KR (1) KR100227541B1 (el)
AT (1) ATE189214T1 (el)
DE (1) DE69606364T2 (el)
DK (1) DK0760366T3 (el)
ES (1) ES2142547T3 (el)
GR (1) GR3033195T3 (el)
PT (1) PT760366E (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007074604A1 (ja) * 2005-12-26 2007-07-05 Ltt Bio-Pharma Co., Ltd. 水溶性非ペプチド性低分子薬物含有ナノ粒子
WO2008101173A2 (en) * 2007-02-16 2008-08-21 Cornell University Biodegradable compositions and materials
WO2008139804A1 (ja) * 2007-05-14 2008-11-20 Ltt Bio-Pharma Co., Ltd. 徐放性の陰荷電基を持つ低分子薬物含有ナノ粒子
AU2009246330B2 (en) * 2008-05-14 2015-04-02 Peter Thomas Roth Labs, Llc Prostaglandin based compositions and method of use thereof
US8569279B2 (en) 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
EP2435049A1 (en) * 2009-05-27 2012-04-04 Sucampo AG Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632627A (en) * 1968-01-05 1972-01-04 Smith Kline French Lab Glyceride derivatives of prostaglandins
US4054736A (en) * 1970-06-10 1977-10-18 Ono Pharmaceutical Co., Ltd. Clathrate compounds of prostaglandins or their analogues with cyclodextrin

Also Published As

Publication number Publication date
DK0760366T3 (da) 2000-04-17
DE69606364T2 (de) 2000-06-08
PT760366E (pt) 2000-07-31
US5698590A (en) 1997-12-16
KR970010743A (ko) 1997-03-27
EP0760366B1 (en) 2000-01-26
ES2142547T3 (es) 2000-04-16
ATE189214T1 (de) 2000-02-15
KR100227541B1 (ko) 1999-11-01
EP0760366A1 (en) 1997-03-05
DE69606364D1 (de) 2000-03-02

Similar Documents

Publication Publication Date Title
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
IL104154A0 (en) Saccharin derivatives,their preparation and pharmaceutical compositions containing them
DE68906609D1 (de) Dopamin-vorlaeufer.
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
KR890003382A (ko) 항 비루스성 화합물
GR3032274T3 (en) Prostaglandin derivatives
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
GR3033195T3 (en) Prostaglandin derivatives
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
AU6826700A (en) Ceramide analogs, process for their preparation and their use as antitumor agents
ES2134441T3 (es) Benzonitrilos terapeuticos.
GR3031908T3 (en) Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
WO2001035938A3 (de) Pharmakologisch aktive tetrahydrothiopyran-4-ol-derivate, verfahren zu ihrer herstellung und verwendung
DE69330269D1 (de) Benzopyran-derivate, deren herstellung sowie diese als aktive bestandteile enthaltende arzneimittel
EP0178176A3 (en) Tetrahydro-1,2,4-oxadiazine-5-thione derivatives
JO1664B1 (en) The compound has the effect of immobilizing gastric acid and the process of preparing it
ITMI930273A0 (it) Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees